Lexicon Pharmaceuticals, Inc.
US ˙ NasdaqCM ˙ US5288723027

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Lonnel Coats. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Veja os Insiders com Maior Classificação
Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Lonnel Coats reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:BPMC / Blueprint Medicines Corporation Director 0
US:LXRX / Lexicon Pharmaceuticals, Inc. Chief Executive Officer, Director 1,098,068
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Lonnel Coats. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas LXRX / Lexicon Pharmaceuticals, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em LXRX / Lexicon Pharmaceuticals, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Máx		 Preço em
Máx		 Lucro
Máx ($)		 Retorno Máx (%)
2023-11-16 LXRX COATS LONNEL 90,000 1.0533 90,000 1.0533 94,797 91 3.5800 227,403 239.88
2023-11-10 LXRX COATS LONNEL 10,000 1.0100 10,000 1.0100 10,100
2023-06-29 LXRX COATS LONNEL 10,000 2.1600 10,000 2.1600 21,600
2023-06-26 LXRX COATS LONNEL 10,000 2.1792 10,000 2.1792 21,792
2023-06-23 LXRX COATS LONNEL 10,000 2.4950 10,000 2.4950 24,950
2023-06-22 LXRX COATS LONNEL 40,000 2.3100 40,000 2.3100 92,400
2019-09-18 LXRX COATS LONNEL 50,000 3.1000 50,000 3.1000 155,000
2019-09-17 LXRX COATS LONNEL 100 3.1250 100 3.1250 312
2019-09-17 LXRX COATS LONNEL 3,000 3.1190 3,000 3.1190 9,357
2019-09-17 LXRX COATS LONNEL 6,333 3.1200 6,333 3.1200 19,759
2019-09-17 LXRX COATS LONNEL 277 3.1296 277 3.1296 867
2019-09-17 LXRX COATS LONNEL 40,290 3.1300 40,290 3.1300 126,108
2019-08-19 LXRX COATS LONNEL 3,000 1.3980 3,000 1.3980 4,194
2019-08-16 LXRX COATS LONNEL 156 1.3250 156 1.3250 207
2019-08-16 LXRX COATS LONNEL 10,044 1.3300 10,044 1.3300 13,359
2019-08-16 LXRX COATS LONNEL 100 1.3350 100 1.3350 134
2019-08-16 LXRX COATS LONNEL 6,600 1.3400 6,600 1.3400 8,844
2019-08-16 LXRX COATS LONNEL 600 1.3450 600 1.3450 807
2019-08-16 LXRX COATS LONNEL 3,500 1.3500 3,500 1.3500 4,725
2019-08-16 LXRX COATS LONNEL 16,000 1.3600 16,000 1.3600 21,760
2017-11-15 LXRX COATS LONNEL 10,000 9.9100 10,000 9.9100 99,100
2017-09-15 LXRX COATS LONNEL 300 12.4866 300 12.4866 3,746
2017-09-15 LXRX COATS LONNEL 300 12.4850 300 12.4850 3,746
2017-09-15 LXRX COATS LONNEL 3,300 12.5200 3,300 12.5200 41,316
2017-09-15 LXRX COATS LONNEL 5,200 12.5400 5,200 12.5400 65,208
2017-09-15 LXRX COATS LONNEL 3,247 12.5366 3,247 12.5366 40,706
2017-09-15 LXRX COATS LONNEL 4,253 12.5300 4,253 12.5300 53,290
2017-09-15 LXRX COATS LONNEL 400 12.5350 400 12.5350 5,014
2017-09-15 LXRX COATS LONNEL 2,400 12.5500 2,400 12.5500 30,120
2017-09-15 LXRX COATS LONNEL 1,951 12.5600 1,951 12.5600 24,505
2017-09-15 LXRX COATS LONNEL 2,000 12.5700 2,000 12.5700 25,140
2017-09-15 LXRX COATS LONNEL 600 12.5166 600 12.5166 7,510
2017-09-15 LXRX COATS LONNEL 300 12.5498 300 12.5498 3,765
2017-09-15 LXRX COATS LONNEL 1,200 12.5766 1,200 12.5766 15,092
2017-09-15 LXRX COATS LONNEL 149 12.5662 149 12.5662 1,872
2017-09-15 LXRX COATS LONNEL 194 12.5100 194 12.5100 2,427
2017-09-15 LXRX COATS LONNEL 400 12.5162 400 12.5162 5,006
2017-09-15 LXRX COATS LONNEL 100 12.5150 100 12.5150 1,252
2017-09-15 LXRX COATS LONNEL 1,200 12.5190 1,200 12.5190 15,023
2017-09-15 LXRX COATS LONNEL 306 12.5370 306 12.5370 3,836
2017-09-15 LXRX COATS LONNEL 300 12.5761 300 12.5761 3,773
2017-09-15 LXRX COATS LONNEL 300 12.6466 300 12.6466 3,794
2017-09-15 LXRX COATS LONNEL 600 12.6166 600 12.6166 7,570
2017-09-15 LXRX COATS LONNEL 300 12.6161 300 12.6161 3,785
2017-09-15 LXRX COATS LONNEL 300 12.6232 300 12.6232 3,787
2017-09-15 LXRX COATS LONNEL 400 12.6361 400 12.6361 5,054

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Vendas Internas LXRX / Lexicon Pharmaceuticals, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em LXRX / Lexicon Pharmaceuticals, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas		 Preço
Reportado		 Ações
Ajustadas		 Preço
Ajustado		 Base de Custos Dias para
Mín		 Preço em
Mín		 Máxima Perda
Evitada ($)		 Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

LXRX / Lexicon Pharmaceuticals, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Lonnel Coats conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual		 Preço
da Ação		 Valor
da Transação		 Valor
Restante
2025-07-21 2025-07-17 4 BPMC Blueprint Medicines Corp
Common Stock 		D - Sale to Issuer -6,144 0 -100.00
2025-06-24 2025-06-18 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 3,902 6,144 174.04 12,812.00 49,992,424 78,716,928
2024-11-22 2024-11-21 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -9,824 2,242 -81.42 94.87 -932,003 212,699
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -213 12,066 -1.73 94.99 -20,233 1,146,149
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -5,287 12,279 -30.10 94.24 -498,247 1,157,173
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale X -4,500 17,566 -20.39 93.15 -419,175 1,636,273
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise X 1,312 22,066 6.32 76.24 100,027 1,682,312
2024-11-22 2024-11-20 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise X 7,500 20,754 56.59 69.79 523,425 1,448,422
2024-06-14 2024-06-12 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2,242 13,254 20.36
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -61,371 1,098,068 -5.29 2.62 -160,792 2,876,938
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 120,383 1,159,439 11.59
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 91,364 1,039,056 9.64
2024-02-29 2024-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33,333 947,692 3.65
2023-11-17 2023-11-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 90,000 914,359 10.92 1.05 94,797 963,094
2023-11-13 2023-11-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,000 824,359 1.23 1.01 10,100 832,603
2023-06-29 2023-06-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,000 814,359 1.24 2.16 21,600 1,759,015
2023-06-26 2023-06-26 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,000 804,359 1.26 2.18 21,792 1,752,859
2023-06-26 2023-06-23 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,000 794,359 1.27 2.50 24,950 1,981,926
2023-06-23 2023-06-21 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2,600 11,012 30.91
2023-06-22 2023-06-22 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 40,000 784,359 5.37 2.31 92,400 1,811,869
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -50,971 744,359 -6.41 2.17 -110,607 1,615,259
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 91,363 795,330 12.98
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33,334 703,967 4.97
2023-03-01 2023-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84,630 670,633 14.44
2022-06-30 2022-06-21 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2,600 8,412 44.74
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -33,333 66,667 -33.33
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -84,630 84,630 -50.00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79,380 0 -100.00
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -48,053 586,003 -7.58 2.85 -136,951 1,670,109
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 33,333 634,056 5.55
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84,630 600,723 16.40
2022-02-28 2022-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79,380 516,093 18.18
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 274,090 274,090
2022-02-14 2022-02-10 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 822,280 822,280
2021-06-04 2021-06-02 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4,500 4,500
2021-06-04 2021-06-02 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2,250 5,812 63.17
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -84,630 169,260 -33.33
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79,380 79,380 -50.00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23,513 0 -100.00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5,362 0 -100.00
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -55,038 436,713 -11.19 7.19 -395,723 3,139,966
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 84,630 491,751 20.79
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79,380 407,121 24.22
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23,513 327,741 7.73
2021-03-02 2021-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,362 304,228 1.79
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 300,000 300,000
2021-02-16 2021-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 100,000 100,000
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4,500 4,500
2020-06-26 2020-06-24 4 BPMC Blueprint Medicines Corp
Common Stock 		A - Award 2,250 3,562 171.49
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units 		M - Exercise -1,312 0 -100.00
2020-06-23 2020-06-19 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise 1,312 1,312
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -79,380 158,760 -33.33
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23,514 23,513 -50.00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5,363 5,362 -50.00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8,390 0 -100.00
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -45,320 298,866 -13.17 2.77 -125,536 827,859
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 79,380 344,186 29.98
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23,514 264,806 9.75
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,363 241,292 2.27
2020-03-03 2020-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,390 235,929 3.69
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 761,660 761,660
2020-02-10 2020-02-06 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 253,890 253,890
2019-09-19 2019-09-18 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 50,000 227,539 28.16 3.10 155,000 705,371
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 40,290 177,539 29.36 3.13 126,108 555,697
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 277 137,249 0.20 3.13 867 429,534
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 6,333 136,972 4.85 3.12 19,759 427,353
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3,000 130,639 2.35 3.12 9,357 407,463
2019-09-18 2019-09-17 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 127,639 0.08 3.12 312 398,872
2019-08-20 2019-08-19 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3,000 127,539 2.41 1.40 4,194 178,300
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 16,000 124,539 14.74 1.36 21,760 169,373
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3,500 108,539 3.33 1.35 4,725 146,528
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 105,039 0.57 1.34 807 141,277
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 6,600 104,439 6.75 1.34 8,844 139,948
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 97,839 0.10 1.34 134 130,615
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,044 97,739 11.45 1.33 13,359 129,993
2019-08-20 2019-08-16 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 156 87,695 0.18 1.32 207 116,196
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		M - Exercise -10,000 11,818 -45.83
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -4,200 0 -100.00 81.59 -342,678
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -3,098 4,200 -42.45 82.48 -255,523 346,416
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		S - Sale -2,702 7,298 -27.02 83.57 -225,806 609,894
2019-08-19 2019-08-15 4 BPMC Blueprint Medicines Corp
Common Stock 		M - Exercise 10,000 10,000 15.01 150,100 150,100
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Restricted Stock Units 		A - Award 1,312 1,312
2019-06-20 2019-06-19 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 4,875 4,875
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -23,513 47,027 -33.33
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5,363 10,725 -33.34
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8,390 8,390 -50.00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -10,835 0 -100.00
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -18,641 87,539 -17.56 5.51 -102,712 482,340
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 23,513 106,180 28.44
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,363 82,667 6.94
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,390 77,304 12.17
2019-03-01 2019-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,835 68,914 18.66
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 238,140 238,140
2019-02-08 2019-02-07 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 442,260 442,260
2018-06-25 2018-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 7,500 51,136 17.19
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -5,362 16,088 -25.00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -8,390 16,780 -33.33
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		M - Exercise -10,836 10,835 -50.00
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -9,494 58,079 -14.05 8.53 -80,984 495,414
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 5,362 67,573 8.62
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,390 62,211 15.59
2018-03-02 2018-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,836 53,821 25.21
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 211,610 211,610
2018-02-12 2018-02-08 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units 		A - Award 70,540 70,540
2017-11-15 2017-11-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 10,000 42,985 30.32 9.91 99,100 425,981
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 32,985 1.23 12.64 5,054 416,802
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 32,585 0.93 12.62 3,787 411,327
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 32,285 0.94 12.62 3,785 407,311
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 31,985 1.91 12.62 7,570 403,542
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 31,385 0.97 12.65 3,794 396,914
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 31,085 0.97 12.58 3,773 390,928
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 306 30,785 1.00 12.54 3,836 385,952
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1,200 30,479 4.10 12.52 15,023 381,567
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 100 29,279 0.34 12.52 1,252 366,427
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 29,179 1.39 12.52 5,006 365,210
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 194 28,779 0.68 12.51 2,427 360,025
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 149 28,585 0.52 12.57 1,872 359,205
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1,200 28,436 4.41 12.58 15,092 357,628
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 27,236 1.11 12.55 3,765 341,806
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 600 26,936 2.28 12.52 7,510 337,147
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 2,000 26,336 8.22 12.57 25,140 331,044
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 1,951 24,336 8.72 12.56 24,505 305,660
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 2,400 22,385 12.01 12.55 30,120 280,932
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 400 19,985 2.04 12.54 5,014 250,512
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 4,253 19,585 27.74 12.53 53,290 245,400
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3,247 15,332 26.87 12.54 40,706 192,211
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 5,200 12,085 75.53 12.54 65,208 151,546
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 3,300 6,885 92.05 12.52 41,316 86,200
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 3,585 9.13 12.48 3,746 44,759
2017-09-18 2017-09-15 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		P - Purchase 300 3,285 10.05 12.49 3,746 41,018
2017-06-23 2017-06-21 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 10,909 43,636 33.33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -8,390 25,170 -25.00
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -10,836 21,671 -33.33
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -5,258 20,767 -20.20 16.45 -86,494 341,617
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 8,390 26,025 47.58
2017-03-01 2017-02-28 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,836 17,635 159.38
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 21,450 21,450
2017-02-13 2017-02-09 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 85,780 85,780
2016-06-27 2016-06-23 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 10,909 32,727 50.00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		M - Exercise -10,835 32,507 -25.00
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes -4,036 6,799 -37.25 9.07 -36,607 61,667
2016-03-02 2016-02-29 4 LXRX LEXICON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 10,835 10,835
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 33,560 33,560
2016-02-16 2016-02-11 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 134,230 134,230
2016-02-05 2016-02-03 4 BPMC Blueprint Medicines Corp
Stock Option (Right to Buy) 		A - Award 21,818 21,818
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Stock Option (Right to Buy) 		A - Award 1,213,600 1,213,600
2015-02-09 2015-02-05 4 LXRX LEXICON PHARMACEUTICALS, INC.
Restricted Stock Units (Phantom Stock) 		A - Award 303,400 303,400
2014-07-08 2014-07-07 4 LXRX LEXICON PHARMACEUTICALS, INC./DE
Stock Option (Right to Buy) 		A - Award 853,500 853,500
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)